Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cseh

Showing results (521-530 of 540) with videos related to

Pageof 54
Sort By:
Frontiers in Oncology|July 26, 2021
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb StudiesAntonio Passaro, Filippo de Marinis, Hai-Yan Tu, et al.
Angewandte Chemie (International Ed. in English)|May 27, 2017
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For PlectinSamuel M Meier, Dominique Kreutz, Lilli Winter, et al.
Persoonia|April 3, 2024
The genus <i>Gautieria</i> (<i>Gomphales</i>) in Europe and the Mediterranean Basin: a morphological and phylogenetic taxonomic revisionJ M Vidal, P Cseh, Z Merényi, et al.
Annals of Hematology|January 9, 2022
Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia majorRoswitha Lüftinger, Natalia Zubarovskaya, Jacques-Emmanuel Galimard, et al.
British Journal of Haematology|January 15, 2016
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study groupAnnamaria M Cseh, Charlotte M Niemeyer, Ayami Yoshimi, et al.
BMJ Open Gastroenterology|February 24, 2026
Association of extraintestinal manifestations and disease severity in paediatric inflammatory bowel disease: a multicentre cohort studyÁgnes Eszter Tímár, Márk Hernádfői, Brigitta Teutsch, et al.
JAMA Oncology|June 15, 2018
Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical TrialGlenwood D Goss, Enriqueta Felip, Manuel Cobo, et al.
International Journal of Clinical Oncology|March 30, 2021
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutationsGee-Chen Chang, David Chi-Leung Lam, Chun-Ming Tsai, et al.
The Review of Scientific Instruments|August 3, 2018
Design, capabilities, and first results of the new laser blow-off system on Wendelstein 7-XTh Wegner, B Geiger, F Kunkel, et al.
Orvosi Hetilap|February 14, 2007
[The results of ovarian cancer therapy in the Hungarian Centers in 2002-2003]Tamás Pulay, Márta Baki, György Bodoky, et al.
Pageof 54

Showing results (521-530 of 540) with videos related to

Sort By:
Pageof 54
Frontiers in Oncology|July 26, 2021
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb StudiesAntonio Passaro, Filippo de Marinis, Hai-Yan Tu, et al.
Angewandte Chemie (International Ed. in English)|May 27, 2017
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For PlectinSamuel M Meier, Dominique Kreutz, Lilli Winter, et al.
Persoonia|April 3, 2024
The genus <i>Gautieria</i> (<i>Gomphales</i>) in Europe and the Mediterranean Basin: a morphological and phylogenetic taxonomic revisionJ M Vidal, P Cseh, Z Merényi, et al.
Annals of Hematology|January 9, 2022
Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia majorRoswitha Lüftinger, Natalia Zubarovskaya, Jacques-Emmanuel Galimard, et al.
British Journal of Haematology|January 15, 2016
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study groupAnnamaria M Cseh, Charlotte M Niemeyer, Ayami Yoshimi, et al.
BMJ Open Gastroenterology|February 24, 2026
Association of extraintestinal manifestations and disease severity in paediatric inflammatory bowel disease: a multicentre cohort studyÁgnes Eszter Tímár, Márk Hernádfői, Brigitta Teutsch, et al.
JAMA Oncology|June 15, 2018
Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical TrialGlenwood D Goss, Enriqueta Felip, Manuel Cobo, et al.
International Journal of Clinical Oncology|March 30, 2021
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutationsGee-Chen Chang, David Chi-Leung Lam, Chun-Ming Tsai, et al.
The Review of Scientific Instruments|August 3, 2018
Design, capabilities, and first results of the new laser blow-off system on Wendelstein 7-XTh Wegner, B Geiger, F Kunkel, et al.
Orvosi Hetilap|February 14, 2007
[The results of ovarian cancer therapy in the Hungarian Centers in 2002-2003]Tamás Pulay, Márta Baki, György Bodoky, et al.
Pageof 54